BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 19123725)

  • 21. The selective use of sentinel node biopsy in ductal carcinoma in situ.
    Bleicher RJ; Giuliano AE
    Arch Surg; 2003 May; 138(5):489. PubMed ID: 12742950
    [No Abstract]   [Full Text] [Related]  

  • 22. A practical approach to breast ductal carcinoma in situ and tumors with an extensive intraductal component.
    King JM
    Pathology; 1994 Apr; 26(2):90-3. PubMed ID: 8090601
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Ductal carcinoma in-situ of the breast; second EORTC consensus meeting.
    van Dongen JA; Holland R; Peterse JL; Fentiman IS; Lagios MD; Millis RR; Recht A
    Eur J Cancer; 1992; 28(2-3):626-9. PubMed ID: 1317200
    [No Abstract]   [Full Text] [Related]  

  • 24. Margins in ductal carcinoma in situ: is bigger really better?
    Morrow M; Katz SJ
    J Natl Cancer Inst; 2012 Apr; 104(7):494-5. PubMed ID: 22440679
    [No Abstract]   [Full Text] [Related]  

  • 25. Ductal Carcinoma In Situ Stage 0 Breast Cancer: When Less May Be Better.
    Harris JV
    JAMA Intern Med; 2016 Jul; 176(7):887. PubMed ID: 27244094
    [No Abstract]   [Full Text] [Related]  

  • 26. Clear cell variant of ductal carcinoma in situ of the breast.
    Terada T
    Breast J; 2012; 18(3):279-80. PubMed ID: 22530727
    [No Abstract]   [Full Text] [Related]  

  • 27. Multicentric adenomyoepithelioma of the breast with atypia and associated ductal carcinoma in situ.
    Han JS; Peng Y
    Breast J; 2010; 16(5):547-9. PubMed ID: 20604795
    [No Abstract]   [Full Text] [Related]  

  • 28. Ductal carcinoma in situ of breast: update 2019.
    Badve SS; Gökmen-Polar Y
    Pathology; 2019 Oct; 51(6):563-569. PubMed ID: 31472981
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Ductal carcinoma in situ of the breast.
    Burstein HJ; Polyak K; Wong JS; Lester SC; Kaelin CM
    N Engl J Med; 2004 Apr; 350(14):1430-41. PubMed ID: 15070793
    [No Abstract]   [Full Text] [Related]  

  • 30. Comparative ultrastructure of atypical ductal hyperplasia, intraductal carcinoma, and infiltrating ductal carcinoma of the breast.
    Goldenberg VE; Goldenberg NS; Sommers SC
    Cancer; 1969 Dec; 24(6):1152-69. PubMed ID: 4311114
    [No Abstract]   [Full Text] [Related]  

  • 31. An audit of breast cancer pathology reporting in Australia in 1995.
    Kricker A; Armstrong B; Smith C; Bilous M; Camaris C; Mayer A; Psarianos T
    Br J Cancer; 1999 May; 80(3-4):563-8. PubMed ID: 10408867
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Endocrine variant of ductal carcinoma in situ of breast: ultrastructural and light microscopical study.
    Ashworth MT; Haqqani MT
    J Clin Pathol; 1986 Dec; 39(12):1355-9. PubMed ID: 2433311
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Ductal carcinoma in situ: progression to invasive cancer is slow and only occurs in a minority of case.
    Prescrire Int; 2013 Dec; 22(144):301. PubMed ID: 24600735
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pathology of high-risk breast lesions and ductal carcinoma in situ.
    Sewell CW
    Radiol Clin North Am; 2004 Sep; 42(5):821-30, v. PubMed ID: 15337418
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Ductal carcinoma in situ and microinvasive disease. American College of Radiology. ACR Appropriateness Criteria.
    Rabinovitch RA; Solin LJ; Shank BM; Haffty BG; Halberg FE; Martinez AA; McCormick B; McNeese MD; Mendenhall NP; Mitchell SE; Taylor ME; Singletary SE; Leibel S
    Radiology; 2000 Jun; 215 Suppl():1137-52. PubMed ID: 11037538
    [No Abstract]   [Full Text] [Related]  

  • 36. Sentinel lymph node involvement in ductal carcinoma in-situ of the breast: two different causes.
    Brouckaert O; Reynders A; Vanderstappen K; Smeets A; Hoeben A; Paridaens R; Christiaens MR; Floris G; Moerman P; Neven P
    Clin Breast Cancer; 2012 Oct; 12(5):378-81. PubMed ID: 23040005
    [No Abstract]   [Full Text] [Related]  

  • 37. Mucocoele-like tumours: more associations and possibly ductal carcinoma in situ?
    Kulka J; Davies JD
    Histopathology; 1993 May; 22(5):511-2. PubMed ID: 8393832
    [No Abstract]   [Full Text] [Related]  

  • 38. [Breast cancer from the viewpoint of the pathologist].
    Reiner A
    Wien Med Wochenschr; 2000; 150(4):58-62. PubMed ID: 10829305
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Part III. The pathobiology of ductal carcinoma in situ.
    Catzavelos C
    Curr Probl Cancer; 2000; 24(3):125-40. PubMed ID: 10919315
    [No Abstract]   [Full Text] [Related]  

  • 40. Standard for the management of ductal carcinoma in situ of the breast (DCIS).
    Morrow M; Strom EA; Bassett LW; Dershaw DD; Fowble B; Harris Ja; O'Malley F; Schnitt SJ; Singletary SE; Winchester DP; ; ; ;
    CA Cancer J Clin; 2002; 52(5):256-76. PubMed ID: 12363325
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.